Featured Publications
Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection.
Kang YF, Zhang X, Yu XH, Zheng Q, Liu Z, Li JP, Sun C, Kong XW, Zhu QY, Chen HW, Huang Y, Xu M, Zhong Q, Zeng YX, Zeng MS. Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection. Nano Lett 2021, 21: 2476-2486. PMID: 33683126, DOI: 10.1021/acs.nanolett.0c04687.Peer-Reviewed Original Research
2022
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
Sun C, Yuan RY, Xie C, Sun JF, Fang XY, Hu YS, Yu XH, Liu Z, Zeng MS, Kang YF. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. J Virol 2022, 96: e0038322. PMID: 35699445, DOI: 10.1128/jvi.00383-22.Peer-Reviewed Original Research
2021
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
Kang YF, Sun C, Zhuang Z, Yuan RY, Zheng Q, Li JP, Zhou PP, Chen XC, Liu Z, Zhang X, Yu XH, Kong XW, Zhu QY, Zhong Q, Xu M, Zhong NS, Zeng YX, Feng GK, Ke C, Zhao JC, Zeng MS. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates. ACS Nano 2021, 15: 2738-2752. PMID: 33464829, DOI: 10.1021/acsnano.0c08379.Peer-Reviewed Original Research